Director lists 8,148 NRIX shares for sale

Issuer affiliate filed a Form 144 listing 8,148 shares of Common Stock for sale.

Rhea-AI Filing Summary

Issuer affiliate filed a Form 144 listing 8,148 shares of Common Stock for sale. The filing also lists multiple 10b5-1 sales by Christine Ring in early 2026, including transactions on 05/01/2026 (5,394 shares, $90,406.68) and 04/30/2026 (3,214 shares, $53,497.99). The securities reported as issuable were Restricted Stock Units dated 05/02/2022.

Insights

Securities Compliance Counsel

Form 144 notifies the SEC of an affiliate’s planned resale of 8,148 shares and lists recent 10b5-1 dispositions.

Form 144 is a notice required when affiliates intend to sell restricted or control securities; it does not itself effect a sale. The filing shows Restricted Stock Units dated 05/02/2022 and identifies multiple 10b5-1 sales by Christine Ring in 2026.

Cash‑flow treatment and whether the listed shares have been sold are not stated here; subsequent transaction filings or broker confirmations would show completion.

Equity Markets Analyst

Multiple scheduled 10b5-1 sales by an insider were executed across early 2026; per‑trade proceeds are shown.

The filing lists specific share counts and proceeds for dates in Q1–Q2 2026, which document disposition activity by Christine Ring. Examples include $124,148.63 for an 04/02/2026 trade of 8,148 shares.

These are transactional disclosures; the broader ownership impact requires outstanding share totals not provided in this excerpt.

Key Figures

Shares listed for sale: 8,148 shares Sale on 05/01/2026: 5,394 shares Proceeds on 05/01/2026: $90,406.68 +4 more

7 metrics

Shares listed for sale 8,148 shares Form 144 securities to be sold line

Sale on 05/01/2026 5,394 shares 10b5-1 sale by Christine Ring

Proceeds on 05/01/2026 $90,406.68 Proceeds reported for 5,394‑share sale on <date>05/01/2026</date>

Sale on 04/30/2026 3,214 shares 10b5-1 sale by Christine Ring

Proceeds on 04/30/2026 $53,497.99 Proceeds reported for 3,214‑share sale on <date>04/30/2026</date>

Sale on 04/02/2026 8,148 shares 10b5-1 sale by Christine Ring

Proceeds on 04/02/2026 $124,148.63 Proceeds reported for 8,148‑share sale on <date>04/02/2026</date>

Key Terms

10b5-1, Restricted Stock Units, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 8148 | 05/02/2022"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the NRIX Form 144 disclose?

The Form 144 discloses an affiliate listed 8,148 shares of common stock for sale. It also lists multiple 10b5-1 sales by Christine Ring with per‑trade share counts and proceeds in early 2026.

Who conducted the sales reported in the NRIX filing?

The filing attributes recent dispositions to Christine Ring under 10b5-1 plans. It lists dated trades and proceeds for each reported transaction in 2026.

What examples of recent sales appear in the NRIX filing?

Examples include 5,394 shares sold on 05/01/2026 for $90,406.68 and 3,214 shares on 04/30/2026 for $53,497.99, per the filing.

Are the securities being sold restricted or from awards for NRIX?

The filing lists the securities as Restricted Stock Units dated 05/02/2022, indicating the shares originate from an issuer grant rather than open‑market purchases.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001817199
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NURIX THERAPEUTICS INC
SEC File Number	001-39398
Address of Issuer	1600 Sierra Point Parkway Brisbane CALIFORNIA 94005
Phone	4156605320
Name of Person for Whose Account the Securities are To Be Sold	CHRISTINE RING
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8148	136967.88	103405813	05/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/02/2022	Restricted Stock Units	Issuer			8148	05/02/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	05/01/2026	5394	90406.68
CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	04/30/2026	3214	53497.99
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	04/02/2026	8148	124148.63
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	03/02/2026	8148	125792.90
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	02/09/2026	8148	135757.90
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	02/09/2026	6113	101860.92

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 05/02/2022 through 04/30/2025.
Date of Notice	05/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christine Ring
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)